A major advance in cancer study is arising with the use of VHH fragments to re-engage dysfunctional p53. This essential cancer protector protein is frequently inactivated in various kinds of tumors, leading https://listfav.com/story23814667/mini-antibodies-revive-p53-the-potential-pathway-for-cancer-management